AC Immune S.A. (ACIU) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for AC Immune S.A., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.56x | -4.80x | -6.56x | -2.23x | -4.63x | -5.32x |
| P/B Ratio | 5.58x | 2.18x | 2.22x | 0.93x | 1.46x | 1.53x |
| P/S Ratio | 70.23x | 8.95x | 24.06x | 40.03x | 0.00x | 21.33x |
| Profitability | ||||||
| Gross Margin | 100.0% | -129.1% | -268.9% | 100.0% | 0.0% | -285.5% |
| Operating Margin | -1927.3% | -191.8% | -362.3% | -1800.4% | 0.0% | -397.0% |
| Net Margin | -1971.6% | -186.4% | -366.4% | -1798.0% | 0.0% | -401.3% |
| EBITDA Margin | -1896.2% | -178.0% | -350.2% | -1728.7% | 0.0% | -387.0% |
| Liquidity | ||||||
| Current Ratio | 1.02x | 1.71x | 9.22x | 11.16x | 10.12x | 16.53x |
| Quick Ratio | 1.02x | 1.71x | 9.22x | 11.16x | 10.12x | 16.53x |
| Leverage | ||||||
| Debt/Equity | 0.10x | 0.05x | 0.02x | 0.02x | 0.01x | 0.01x |
YoY = year-over-year change. Source: FMP..